Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbott Labs | NYSE | Healthcare | Healthcare Equipment & Supplies | US$228.13B | 17.1x | 0.13 | US$131.47 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 3.2% Upside | Upgrade to Pro+ | |
Intuitive Surgical | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$215.70B | 92.4x | 3.31 | US$605.21 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.1% Upside | Upgrade to Pro+ | |
Thermo Fisher Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | US$201.31B | 31.9x | 4.59 | US$526.32 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.1% Upside | Upgrade to Pro+ | |
Boston Scientific | NYSE | Healthcare | Healthcare Equipment & Supplies | US$155.11B | 83.6x | 5.02 | US$105.18 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12% Upside | Upgrade to Pro+ | |
Stryker | NYSE | Healthcare | Healthcare Equipment & Supplies | US$147.35B | 49.1x | -8.27 | US$386.04 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.9% Upside | Upgrade to Pro+ | |
Danaher | NYSE | Healthcare | Healthcare Equipment & Supplies | US$145.99B | 38.1x | -2.23 | US$202.62 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.4% Upside | Upgrade to Pro+ | |
Essilor International SA | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$139.37B | 56.3x | 57.93 | US$152.57 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -21.1% Downside | Upgrade to Pro+ | |
Medtronic | NYSE | Healthcare | Healthcare Equipment & Supplies | US$110.37B | 26.3x | 4.59 | US$85.87 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10% Upside | Upgrade to Pro+ | |
Siemens Healthineers ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$65.38B | 31.8x | 1.05 | US$29.29 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.3% Upside | Upgrade to Pro+ | |
Becton Dickinson | NYSE | Healthcare | Healthcare Equipment & Supplies | US$64.82B | 37.9x | 0.91 | US$225.81 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.4% Upside | Upgrade to Pro+ | |
Cencora Inc | NYSE | Healthcare | Healthcare Equipment & Supplies | US$47.37B | 34.4x | -1.44 | US$244.48 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16% Upside | Upgrade to Pro+ | |
Edwards Lifesciences | NYSE | Healthcare | Healthcare Equipment & Supplies | US$44.59B | 10.8x | 0.16 | US$75.36 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.8% Upside | Upgrade to Pro+ | |
Alcon | NYSE | Healthcare | Healthcare Equipment & Supplies | US$44.09B | 37.9x | 0.25 | US$89.14 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.3% Upside | Upgrade to Pro+ | |
GE HealthCare | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$42.17B | 21.3x | 0.49 | US$91.87 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 11.1% Upside | Upgrade to Pro+ | |
Agilent Technologies | NYSE | Healthcare | Healthcare Equipment & Supplies | US$38.81B | 30.7x | 5.2 | US$135.91 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.2% Upside | Upgrade to Pro+ | |
Veeva Systems A | NYSE | Healthcare | Healthcare Equipment & Supplies | US$37.02B | 55.4x | 3.47 | US$227.75 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.5% Upside | Upgrade to Pro+ | |
IDEXX Labs | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$36.69B | 41.7x | 6.76 | US$448.66 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.8% Upside | Upgrade to Pro+ | |
DexCom | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$35.55B | 62x | 6.46 | US$90.91 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.1% Upside | Upgrade to Pro+ | |
Resmed ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$34.22B | 28.3x | 0.68 | US$21.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ResMed | NYSE | Healthcare | Healthcare Equipment & Supplies | US$34.15B | 27.4x | 0.68 | US$232.53 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.3% Upside | Upgrade to Pro+ | |
Coloplast A | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$24.98B | 36.6x | -14.13 | US$11.11 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.2% Upside | Upgrade to Pro+ | |
Straumann ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$23.66B | 78.9x | -2.52 | US$14.73 | 3.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 12.6% Upside | Upgrade to Pro+ | |
Koninklijke Philips ADR | NYSE | Healthcare | Healthcare Equipment & Supplies | US$23.34B | -66.9x | -1.18 | US$25.12 | -11.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Waters | NYSE | Healthcare | Healthcare Equipment & Supplies | US$22.37B | 35.1x | -28.7 | US$376.87 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.1% Upside | Upgrade to Pro+ | |
STERIS | NYSE | Healthcare | Healthcare Equipment & Supplies | US$21.60B | 46.4x | -2.07 | US$219.73 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.8% Upside | Upgrade to Pro+ | |
Zimmer Biomet | NYSE | Healthcare | Healthcare Equipment & Supplies | US$20.39B | 23x | -2.4 | US$102.42 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 15.8% Upside | Upgrade to Pro+ | |
Insulet | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$20.15B | 47.8x | 0.2 | US$286.81 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.8% Upside | Upgrade to Pro+ | |
Sonova Holding AG | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$19.63B | 31.5x | -5.42 | US$65.80 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20.7% Upside | Upgrade to Pro+ | |
Cooper | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$17.20B | 43.8x | 1.38 | US$86.08 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.7% Upside | Upgrade to Pro+ | |
Illumina | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$16.29B | -12.6x | 0.34 | US$102.07 | 1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.4% Upside | Upgrade to Pro+ | |
Baxter | NYSE | Healthcare | Healthcare Equipment & Supplies | US$15.69B | 144.8x | -1.36 | US$30.71 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.6% Upside | Upgrade to Pro+ | |
Align | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$15.03B | 35.7x | -11.2 | US$201.13 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.6% Upside | Upgrade to Pro+ | |
West Pharmaceutical Services | NYSE | Healthcare | Healthcare Equipment & Supplies | US$14.65B | 30.4x | -2.09 | US$202.24 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.2% Upside | Upgrade to Pro+ | |
Hologic | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$14.34B | 20.1x | 0.38 | US$63.93 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.1% Upside | Upgrade to Pro+ | |
Revvity | NYSE | Healthcare | Healthcare Equipment & Supplies | US$13.76B | 51.3x | -0.8 | US$113.02 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.7% Upside | Upgrade to Pro+ | |
Solventum | NYSE | Healthcare | Healthcare Equipment & Supplies | US$12.83B | 16.9x | -0.37 | US$74.16 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1% Downside | Upgrade to Pro+ | |
Fisher Paykel Healthcare | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$11.86B | 115.6x | -3.64 | US$19.97 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Penumbra Inc | NYSE | Healthcare | Healthcare Equipment & Supplies | US$11.78B | 341.7x | -18.7 | US$307 | 13.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2% Upside | Upgrade to Pro+ | |
Avantor | NYSE | Healthcare | Healthcare Equipment & Supplies | US$11.70B | 16.4x | 0.14 | US$17.18 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 44.1% Upside | Upgrade to Pro+ | |
Globus Medical | NYSE | Healthcare | Healthcare Equipment & Supplies | US$11.60B | 126.6x | -2.31 | US$84.99 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.4% Upside | Upgrade to Pro+ | |
CochLear ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$11.58B | 48.9x | 7.66 | US$87.70 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Smith&Nephew SNATS | NYSE | Healthcare | Healthcare Equipment & Supplies | US$11.19B | 36.8x | 0.93 | US$25.61 | -1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.6% Upside | Upgrade to Pro+ | |
Masimo | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$9.80B | 123.8x | -10.89 | US$182.96 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.4% Upside | Upgrade to Pro+ | |
Henry Schein | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$9.64B | 31.6x | -1.09 | US$77.28 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.2% Upside | Upgrade to Pro+ | |
Glaukos Corp | NYSE | Healthcare | Healthcare Equipment & Supplies | US$8.66B | -53.6x | 6.26 | US$157.12 | 2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.9% Upside | Upgrade to Pro+ | |
Repligen | NASDAQ | Healthcare | Healthcare Equipment & Supplies | US$8.29B | -1,030x | 9.4 | US$148.01 | 2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.2% Upside | Upgrade to Pro+ | |
Teleflex | NYSE | Healthcare | Healthcare Equipment & Supplies | US$8.09B | 34.2x | -0.79 | US$174.11 | 2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.3% Upside | Upgrade to Pro+ | |
Bio-Rad Labs | NYSE | Healthcare | Healthcare Equipment & Supplies | US$7.98B | -4.3x | 0.02 | US$284.15 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.3% Upside | Upgrade to Pro+ | |
Demant ADR | OTC Markets | Healthcare | Healthcare Equipment & Supplies | US$7.95B | 24.4x | 0.53 | US$17.97 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bio-Rad Labs B | NYSE | Healthcare | Healthcare Equipment & Supplies | US$7.88B | -4.3x | 0.02 | US$281.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |